PacBio Corp (PACB) - יתרות מזומנים בחישוב למניה

The B2B model of Pacific Biosciences (PACB) with the Revio system ensures stable revenue from consumables. The cash per share history on the GURU.Markets platform chart confirms this resilience, where the 0.64 mark indicates the current state of liquidity. Success is based on leadership in HiFi sequencing and AI developments, as well as the attraction of elite scientists through a stock option system.
פילוחי מדדים מקיפים ואנליטיקה עבור PacBio Corp (PACB)

As a technological leader in DNA sequencing, Pacific Biosciences (PACB) requires constant liquidity monitoring to fund R&D. This metric is calculated as the ratio of net cash to the number of shares, reflecting real solvency and management's ability to curb cash burn. By analyzing cash per share trends, an investor assesses the balance between financial stability and the efficiency of capital investment in product commercialization.